Schott Pharma stock trades at 22.83 euros on Thursday

Published on 11/05/2026 at 13:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Schott Pharma stock remains in focus ahead of three investor events in November. The company supplies containment and delivery solutions for injectable drugs.

Investor calendar sets next dates

SCHOTT Pharma has investor meetings scheduled for November 17, 18 and 19, 2026.
The company supplies containment and delivery solutions for injectable drugs.

Schott Pharma, DE000A3ENQ51, Illustration mit AI erstellt.

Schott Pharma stock traded at 22.83 euros on Lang & Schwarz at 13:02 CET on Thursday, November 5, 2026.

SCHOTT Pharma's investor calendar lists three industry events for the second half of November. The company is scheduled to attend the BNP Midcap CEO Conference on November 17, the LBBW German Company Day on November 18 and the Jefferies Global Healthcare Conference on November 19, according to its investor relations page.

Focus on injectable medicines

SCHOTT Pharma describes itself as a global supplier of high-end containment and delivery solutions for injectable drugs. Its investor materials highlight a broad product portfolio, a global production network and relationships with pharmaceutical customers and industry partners.

The November meetings give investors several near-term opportunities to hear from management and assess the company's growth strategy. The published schedule does not provide additional details on the topics or financial targets for those meetings.